Neurology & Neurotherapeutics - NE Multiple Sclerosis Section

Research output

Research output per year 1986 2008 2009 2010 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 489 Article
• 119 Review article
• 42 Letter
• 21 Editorial
• 30 More
  • 15 Comment/debate
  • 10 Chapter
  • 3 Short survey
  • 1 Book
  • 1 Conference contribution

Research output per year

Research output per year

Search results

• 20/40 or better visual acuity after optic neuritis: Not as good as we once thought?

  Sabadia, S. B., Nolan, R. C., Galetta, K. M., Narayana, K. M., Wilson, J. A., Calabresi, P. A., Frohman, E., Galetta, S. L. & Balcer, L. J., 2016, In: Journal of Neuro-Ophthalmology. 36, 4, p. 369-376 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Optic Neuritis 100%
  • Visual Acuity 67%
  • Eye 35%
  • Nerve Fibers 27%
  • Ganglia 27%
  27 Scopus citations

• Abnormal thalamic functional connectivity correlates with cardiorespiratory fitness and physical activity in progressive multiple sclerosis

  CogEx Research Team, Jun 2023, In: Journal of neurology. 270, 6, p. 3213-3224 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Cardiorespiratory Fitness 100%
  • Multiple Sclerosis 68%
  • Exercise 50%
  • White Matter 20%
  • Atrophy 19%
  3 Scopus citations

• Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event

  Corvol, J. C., Pelletier, D., Henry, R. G., Caillier, S. J., Wang, J., Pappas, D., Casazza, S., Okuda, D. T., Hauser, S. L., Oksenberg, J. R. & Baranzini, S. E., Aug 19 2008, In: Proceedings of the National Academy of Sciences of the United States of America. 105, 33, p. 11839-11844 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • T-Lymphocytes 70%
  • Supervised Machine Learning 25%
  • Gene Expression 19%
  • Autoimmune Experimental Encephalomyelitis 18%
  93 Scopus citations

• A Callosal Catastrophe: Toxic Leukoencephalopathy Associated with Thermogenic Weight Loss Supplement Use

  Mahdavi, Z. K., Narayan, R., Mainali, S., Greenberg, B. M., Aiyagari, V. & McDonagh, D. L., Dec 1 2018, In: Neurocritical Care. 29, 3, p. 504-507 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Leukoencephalopathies 100%
  • Corpus Callosum 83%
  • Dietary Supplements 76%
  • Hyponatremia 66%
  • Weight Loss 61%
  1 Scopus citations

• A case-control study of dietary salt intake in pediatric-onset multiple sclerosis

  McDonald, J., Graves, J., Waldman, A., Lotze, T., Schreiner, T., Belman, A., Greenberg, B., Weinstock-Guttman, B., Aaen, G., Tillema, J. M., Hart, J., Lulu, S., Ness, J., Harris, Y., Rubin, J., Candee, M., Krupp, L. B., Gorman, M., Benson, L., Rodriguez, M., & 9 othersChitnis, T., Mar, S., Barcellos, L. F., Laraia, B., Rose, J., Roalstad, S., Simmons, T., Casper, T. C. & Waubant, E., Mar 1 2016, In: Multiple Sclerosis and Related Disorders. 6, p. 87-92 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Salts 99%
  • Sodium 94%
  • Case-Control Studies 91%
  • Pediatrics 72%
  56 Scopus citations

• A case of Susac syndrome with cervical spinal cord involvement on MRI

  Hua, L. H., Donlon, S. L. & Okuda, D. T., Feb 15 2014, In: Journal of the Neurological Sciences. 337, 1-2, p. 228-231 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Susac Syndrome 100%
  • Cervical Cord 66%
  • Magnetic Resonance Imaging 37%
  • Brain Diseases 27%
  • Retinal Artery Occlusion 20%
  23 Scopus citations

• A Case of Vestibular Migraine Resolving on Warfarin and Topiramate

  Beh, S. C., Apr 2018, In: Headache. 58, 4, p. 599-600 2 p.

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• Accuracy of clinical detection of INO in MS: Corroboration with quantitative infrared oculography

  Frohman, T. C., Frohman, E., O'Suilleabhain, P. E., Salter, A., Dewey, R. B., Hogan, R. N., Galetta, S., Lee, A. G., Straumann, D., Noseworthy, J., Zee, D., Corbett, J., Corboy, J., Rivera, V. M. & Kramer, P. D., Sep 23 2003, In: Neurology. 61, 6, p. 848-850 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Ophthalmoplegia 100%
  • Physicians 11%
  59 Scopus citations

• Acquired sexual paraphilia in patients with multiple sclerosis

  Frohman, E., Frohman, T. C. & Moreault, A. M., 2002, In: Archives of neurology. 59, 6, p. 1006-1010 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Paraphilic Disorders 100%
  • Multiple Sclerosis 88%
  • Sexual 46%
  • Sexual Behavior 29%
  • Brain Lesion 17%
  35 Scopus citations

• Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis

  Aaen, G., Waltz, M., Vargas, W., Makhani, N., Ness, J., Harris, Y., Casper, T. C., Benson, L., Candee, M., Chitnis, T., Gorman, M., Graves, J., Greenberg, B., Lotze, T., Mar, S., Tillema, J. M., Rensel, M., Rodriguez, M., Rose, J., Rubin, J., & 6 othersSchreiner, T., Waldman, A., Weinstock-Guttman, B., Belman, A., Waubant, E. & Krupp, L., Mar 1 2019, In: Journal of child neurology. 34, 3, p. 148-152 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Special Education 100%
  • Multiple Sclerosis 62%
  • Pediatrics 45%
  • Walking 24%
  • Child 18%
  4 Scopus citations

• A cross-sectional natural history study of aspartylglucosaminuria

  Goodspeed, K., Horton, D. K., Lowden, A., Sguigna, P. V., Booth, T., Wang, Z. J. & Edgar, V. B., Sep 2022, In: JIMD Reports. 63, 5, p. 425-433 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Aspartylglucosaminuria 100%
  • Natural History 55%
  • Magnetic Resonance Spectroscopy 50%
  • Biological Marker 49%
  • Biomarkers 21%
  2 Scopus citations

• Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning

  Ratchford, J. N., Saidha, S., Sotirchos, E. S., Oh, J. A., Seigo, M. A., Eckstein, C., Durbin, M. K., Oakley, J. D., Meyer, S. A., Conger, A., Frohman, T. C., Newsome, S. D., Balcer, L. J., Frohman, E. & Calabresi, P. A., Jan 1 2013, In: Neurology. 80, 1, p. 47-54 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Retinal Ganglion Cells 100%
  • Multiple Sclerosis 77%
  • Ganglia 60%
  • Optical Coherence Tomography 37%
  • Gadolinium 27%
  179 Scopus citations

• Acute Disseminated Encephalomyelitis (ADEM) and Increased Intracranial Pressure Associated With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies

  Narayan, R. N., Wang, C. & Greenberg, B. M., Oct 2019, In: Pediatric Neurology. 99, p. 64-68 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Acute Disseminated Encephalomyelitis 100%
  • Myelin-Oligodendrocyte Glycoprotein 79%
  • Oligodendroglia 75%
  • Intracranial Pressure 75%
  • Glycoproteins 58%
  13 Scopus citations

• Acute flaccid myelitis: Long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitis

  Greenberg, B., Plumb, P., Cutter, G., Dean, J., Desena, A., Hopkins, S., Krishnan, C., Pardo, C., Recio, A., Schreiner, T., Yeh, E. A. & McCreary, M., May 19 2021, In: BMJ Neurology Open. 3, 1, e000127.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • acute flaccid myelitis 100%
  • Transverse Myelitis 76%
  • Pediatrics 34%
  • Myelitis 29%
  • North America 5%
  6 Scopus citations

• Acute flaccid myelitis: cause, diagnosis, and management

  AFM working group, Jan 23 2021, In: The Lancet. 397, 10271, p. 334-346 13 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • acute flaccid myelitis 100%
  • Rehabilitation 16%
  • Enterovirus Infections 15%
  • Poliomyelitis 12%
  • Muscle Weakness 11%
  81 Scopus citations

• Acute optic neuritis: A clinical paradigm for evaluation of neuroprotective and restorative strategies?

  Qureshi, S. S. & Frohman, E., Oct 30 2015, In: Neural Regeneration Research. 10, 10, p. 1599-1601 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access
  1 Scopus citations

• Acute pathological laughter

  Okuda, D. T., Chyung, A. S. C., Chin, C. T. & Waubant, E., Oct 2005, In: Movement Disorders. 20, 10, p. 1389-1390 2 p.

  Research output: Contribution to journal › Article › peer-review

  • Cerebral Peduncle 100%
  • Laughter 96%
  • Crying 84%
  • Central Nervous System Diseases 71%
  • Gadolinium 70%
  15 Scopus citations

• Acute weakness: A practical step-by-step approach to distinguishing myelopathy from neuropathy

  Greenberg, B. M. & Kerr, D., Oct 2006, In: Advanced Studies in Medicine. 6, 9, p. 391-398 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Spinal Cord Diseases 100%
  • Textbooks 15%
  • Expert Testimony 13%
  • Paralysis 12%
  • Spinal Cord Injuries 12%
  1 Scopus citations

• Adaptive lymphocyte profiles correlate to brain Aβ burden in patients with mild cognitive impairment

  Stowe, A. M., Ireland, S. J., Ortega, S. B., Chen, D., Huebinger, R. M., Tarumi, T., Harris, T. S., Cullum, C. M., Rosenberg, R., Monson, N. L. & Zhang, R., Jul 27 2017, In: Journal of Neuroinflammation. 14, 1, 149.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cerebrospinal Fluid 100%
  • Cognitive Dysfunction 94%
  • Lymphocytes 79%
  • Amyloid 62%
  • Brain 56%
  11 Scopus citations

• Addressing the challenges in risk assessment and risk management in multiple sclerosis

  Frohman, E., Greenberg, B., Ratchford, J. & Zivadinov, R., Mar 1 2012, In: Johns Hopkins Advanced Studies in Medicine. 12, 1, p. 6-16 11 p.

  Research output: Contribution to journal › Article › peer-review

• A distinct class of antibodies may be an indicator of gray matter autoimmunity in early and established relapsing remitting multiple sclerosis patients

  Ligocki, A. J., Rivas, J. R., Rounds, W. H., Guzman, A. A., Li, M., Spadaro, M., Lahey, L., Chen, D., Henson, P. M., Graves, D., Greenberg, B., Frohman, E., Ward, E. S., Robinson, W., Meinl, E., White, C. L., Stowe, A. M. & Monson, N. L., Oct 21 2015, In: ASN Neuro. 7, 5

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Relapsing-Remitting Multiple Sclerosis 100%
  • Immunoglobulin Isotypes 94%
  • Gray Matter 81%
  • Autoimmunity 78%
  • Antibodies 44%
  14 Scopus citations

• Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry

  Chi, C., Shao, X., Rhead, B., Gonzales, E., Smith, J. B., Xiang, A. H., Graves, J., Waldman, A., Lotze, T., Schreiner, T., Weinstock-Guttman, B., Aaen, G., Tillema, J. M., Ness, J., Candee, M., Krupp, L., Gorman, M., Benson, L., Chitnis, T., Mar, S., & 13 othersBelman, A., Casper, T. C., Rose, J., Moodley, M., Rensel, M., Rodriguez, M., Greenberg, B., Kahn, L., Rubin, J., Schaefer, C., Waubant, E., Langer-Gould, A. & Barcellos, L. F., 2019, In: PLoS genetics. 15, 1, e1007808.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • sclerosis 100%
  • antigen 85%
  • ancestry 78%
  • allele 74%
  • HLA antigens 65%
  42 Scopus citations

• A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse

  Greenberg, B. M., Bowen, J. D., Alvarez, E., Rodriguez, M., Caggiano, A. O., Warrington, A. E., Zhao, P. & Eisen, A., Apr 2022, In: Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8, 2

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Intravenous Infusions 100%
  • Multiple Sclerosis 90%
  • Immunoglobulins 90%
  • Placebos 70%
  • Recurrence 58%
  2 Scopus citations

• A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis

  Eisen, A., Greenberg, B. M., Bowen, J. D., Arnold, D. L. & Caggiano, A. O., Oct 1 2017, In: Multiple Sclerosis Journal - Experimental, Translational and Clinical. 3, 4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Placebos 78%
  • Antibodies 62%
  • Pharmacokinetics 56%
  • Safety 22%
  27 Scopus citations

• Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database

  Caldito, N. G., Shirani, A., Salter, A. & Stuve, O., Jun 2021, In: Multiple Sclerosis Journal. 27, 7, p. 1066-1076 11 p.

  Research output: Contribution to journal › Article › peer-review

  • ocrelizumab 100%
  • Rituximab 61%
  • Databases 33%
  • United States Food and Drug Administration 11%
  • Multiple Sclerosis 9%
  23 Scopus citations

• African Americans experience disproportionate neurodegenerative changes in the medulla and upper cervical spinal cord in early multiple sclerosis

  Moog, T. M., McCreary, M., Stanley, T., Wilson, A., Santoyo, J., Wright, K., Winkler, M. D., Wang, Y., Yu, F., Newton, B. D., Zeydan, B., Kantarci, O., Guo, X. & Okuda, D. T., Oct 2020, In: Multiple Sclerosis and Related Disorders. 45, 102429.

  Research output: Contribution to journal › Article › peer-review

  • Cervical Cord 100%
  • African Americans 80%
  • Multiple Sclerosis 75%
  • European Continental Ancestry Group 68%
  • Compliance 22%
  19 Scopus citations

• Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies

  Porwal, M. H., Salter, A., Patel, D. & Obeidat, A. Z., Jun 2022, In: Journal of Central Nervous System Disease. 14

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Alopecia 100%
  • Multiple Sclerosis 82%
  • teriflunomide 78%
  • ocrelizumab 61%
  • Dimethyl Fumarate 54%
  3 Scopus citations

• Alteration of the CD34⁺ Tf-1β cell line profile in response to long-term exposure to IL-15

  Farner, N. L., Gan, J., De Jong, J. L. O., Leary, T. P., Fenske, T. S., Buckley, P., Dunlap, S. & Sondel, P. M., May 1997, In: Cytokine. 9, 5, p. 316-327 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Interleukin-15 100%
  • Interleukin-2 70%
  • Marker 68%
  • Erythropoietin 56%
  • Proliferative 52%
  13 Scopus citations

• Altered CD4⁺/CD8⁺ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis

  Stuve, O., Marra, C. M., Bar-Or, A., Niino, M., Cravens, P. D., Cepok, S., Frohman, E., Phillips, J. T., Arendt, G., Jerome, K. R., Cook, L., Grand'Maison, F., Hemmer, B., Monson, N. L. & Racke, M. K., 2006, In: Archives of neurology. 63, 10, p. 1383-1387 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Natalizumab 100%
  • Multiple Sclerosis 99%
  • Cerebrospinal Fluid 60%
  • Cells 49%
  • T-Lymphocytes 43%
  251 Scopus citations

• Altered task-induced cerebral blood flow and oxygen metabolism underlies motor impairment in multiple sclerosis

  West, K. L., Sivakolundu, D. K., Zuppichini, M. D., Turner, M. P., Spence, J. S., Lu, H., Okuda, D. T. & Rypma, B., Jan 2021, In: Journal of Cerebral Blood Flow and Metabolism. 41, 1, p. 182-193 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cerebrovascular Circulation 100%
  • Multiple Sclerosis 91%
  • Oxygen 73%
  • Motor Cortex 52%
  • Thumb 39%
  4 Scopus citations

• A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica

  NEMOS (Neuromyelitis Optica Study Group in Germany), NOMADMUS (Neuromyelitis Optica study Group in France), OFSEP (Observatoire Français de la Sclérose en Plaques) investigators, Oct 2021, In: Annals of Clinical and Translational Neurology. 8, 10, p. 2025-2037 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neuromyelitis Optica 100%
  • Rituximab 80%
  • Mycophenolic Acid 65%
  • Azathioprine 61%
  • Immunosuppressive Agents 61%
  18 Scopus citations

• A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of avonex in patients with multiple sclerosis

  Phillips, J. T., Rice, G., Frohman, E., Vande Gaer, L., Scott, T., Haas, J., Eggenberger, E., Freedman, M. S., Stuart, W., Cunha, L., Jacobs, L., Oger, J., Arnold, D., Murray, J., DiBiase, M., Jethwa, V. & Goelz, S., Apr 2004, In: Clinical Therapeutics. 26, 4, p. 511-521 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Prefil 100%
  • Interferon beta-1a 93%
  • Syringes 70%
  • Multiple Sclerosis 55%
  • Human Serum Albumin 37%
  30 Scopus citations

• Amyloid burden and sleep blood pressure in amnestic mild cognitive impairment

  Tarumi, T., Harris, T. S., Hill, C., German, Z., Riley, J., Turner, M., Womack, K. B., Kerwin, D. R., Monson, N. L., Stowe, A. M., Mathews, D., Cullum, C. M. & Zhang, R., Dec 1 2015, In: Neurology. 85, 22, p. 1922-1929 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Amyloid 100%
  • Cognitive Dysfunction 86%
  • Sleep 82%
  • Blood Pressure 67%
  • Gyrus Cinguli 60%
  29 Scopus citations

• Analysis of 30 spinal angiograms falsely reported as normal in 18 patients with subsequently documented spinal vascular malformations

  Barreras, P., Heck, D., Greenberg, B., Wolinsky, J. P., Pardo, C. A. & Gailloud, P., Sep 1 2017, In: American Journal of Neuroradiology. 38, 9, p. 1814-1819 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Vascular Malformations 100%
  • Arteriovenous Fistula 70%
  • Angiography 65%
  • Central Nervous System Vascular Malformations 28%
  • Early Diagnosis 16%
  24 Scopus citations

• Analysis of Agreement of Retinal-Layer Thickness Measures Derived from the Segmentation of Horizontal and Vertical Spectralis OCT Macular Scans

  Gonzalez Caldito, N., Antony, B., He, Y., Lang, A., Nguyen, J., Rothman, A., Ogbuokiri, E., Avornu, A., Balcer, L., Frohman, E., Frohman, T. C., Bhargava, P., Prince, J., Calabresi, P. A. & Saidha, S., Mar 4 2018, In: Current Eye Research. 43, 3, p. 415-423 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Retinaldehyde 100%
  • Optical Coherence Tomography 67%
  • Multiple Sclerosis 29%
  • Nerve Fibers 11%
  • Ganglia 11%
  10 Scopus citations

• A narrative review of neuro-ophthalmologic disease in African Americans and Hispanics with multiple sclerosis

  Tardo, L., Salter, A., Truong-Le, M., Horton, L., Blackburn, K. M. & Sguigna, P. V., Jan 1 2023, In: Therapeutic Advances in Chronic Disease. 14

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Hispanic Americans 100%
  • African Americans 97%
  • Multiple Sclerosis 91%
  • Ocular Vision 58%
  • Eye Diseases 36%

• A new measure of dysconjugacy in INO: The first-pass amplitude

  Frohman, E., O'Suilleabhain, P. E., Dewey, R. B., Frohman, T. C. & Kramer, P. D., Jun 15 2003, In: Journal of the Neurological Sciences. 210, 1-2, p. 65-71 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Ophthalmoplegia 100%
  • Eye Movements 31%
  • Multiple Sclerosis 26%
  • Acceleration 14%
  • Eye 9%
  25 Scopus citations

• An in vivo assessment of the brain in Alzheimer's disease.

  Frohman, E. & van den Noort, S., Apr 1 1986, In: The Western journal of medicine. 144, 4, 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Anna-3 associated stiff-person-syndrome

  Zeiler, S. R., Jordan, J. D., Greenberg, B. M. & Kaplan, P. W., 2010, In: Journal of Cancer Science and Therapy. 2, 1, p. 1-2 2 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• Anomalies Characteristic of Central Nervous System Demyelination: Radiologically Isolated Syndrome

  RISConsortium, Feb 2018, In: Neurologic Clinics. 36, 1, p. 59-68 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Demyelinating Diseases 100%
  • Multiple Sclerosis 83%
  • Central Nervous System 70%
  • White Matter 43%
  • Spinal Cord 38%
  12 Scopus citations

• Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased inflammatory and reduced regulatory B cell capacity

  Ireland, S. J., Blazek, M., Harp, C. T., Greenberg, B., Frohman, E. M., Davis, L. S. & Monson, N. L., Aug 2012, In: Autoimmunity. 45, 5, p. 400-414 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Regulatory B-Lymphocytes 100%
  • B-Lymphocyte Subsets 83%
  • Relapsing-Remitting Multiple Sclerosis 82%
  • B-Lymphocytes 51%
  • Antibodies 36%
  57 Scopus citations

• Antibody Testing for Neurological Autoimmune Disorders: Evaluation of Best Practices at a Tertiary Referral Center

  Fredrich, S. E., Vernino, S. & Blackburn, K. M., Jun 30 2021, In: Frontiers in Neurology. 12, 690415.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Nervous System Diseases 100%
  • Practice Guidelines 99%
  • Tertiary Care Centers 93%
  • Antibodies 59%
  • Clinical Decision-Making 56%
  2 Scopus citations

• Anticipated benefits and surprising effects of daclizumab in multiple sclerosis

  Stüve, O. & Greenberg, B. M., Apr 2010, In: The Lancet Neurology. 9, 4, p. 337-338 2 p.

  Research output: Contribution to journal › Letter › peer-review
  4 Scopus citations

• Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS

  Washington, D. L., O'Connor, K. C., Cameron, E. M., Jowdry, A., Ward, E. S., Frohman, E., Racke, M. K. & Monson, N. L., May 2007, In: Journal of Neuroimmunology. 186, 1-2, p. 164-176 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Myelin Basic Protein 100%
  • Cerebrospinal Fluid 71%
  • Immunoglobulin Fab Fragments 70%
  • B-Lymphocytes 63%
  • Antigens 52%
  46 Scopus citations

• Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated With Gray Matter Predominant Transverse Myelitis Mimicking Acute Flaccid Myelitis: A Presentation of Two Cases

  Wang, C., Narayan, R. & Greenberg, B., Sep 2018, In: Pediatric Neurology. 86, p. 42-45 4 p.

  Research output: Contribution to journal › Article › peer-review

  • acute flaccid myelitis 100%
  • Myelin-Oligodendrocyte Glycoprotein 76%
  • Transverse Myelitis 76%
  • Gray Matter 53%
  • Antibodies 29%
  20 Scopus citations

• Antinuclear antibodies in neuromyelitis optica: Guardians of the brain?

  Monson, N., Feb 1 2016, In: European Journal of Neurology. 23, 2, p. 223-224 2 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access
  3 Scopus citations

• An unusual variant of the dorsal midbrain syndrome in MS: Clinical characteristics and pathopysiologic mechanisms

  Frohman, E., Dewey, R. B. & Frohman, T. C., Jun 2004, In: Multiple Sclerosis. 10, 3, p. 322-325 4 p.

  Research output: Contribution to journal › Review article › peer-review

  • Mesencephalon 100%
  • Eye 59%
  • Pathologic Nystagmus 45%
  • Ocular Motility Disorders 22%
  • Saccades 18%
  17 Scopus citations

• An update on neuro-ophthalmology of multiple sclerosis: The visual system as a model to study multiple sclerosis

  Qureshi, S. S., Beh, S. C., Frohman, T. C. & Frohman, E., Jun 2014, In: Current opinion in neurology. 27, 3, p. 300-308 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Ophthalmology 100%
  • Multiple Sclerosis 84%
  • Myelin Sheath 33%
  • Health Care Outcome Assessment 21%
  • Eye Manifestations 20%
  8 Scopus citations

• A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS)

  Remington, G. M., Treadaway, K., Frohman, T., Salter, A., Stuve, O., Racke, M. K., Hawker, K., Agosta, F., Sormani, M. P., Filippi, M. & Frohman, E., Jan 2010, In: Therapeutic Advances in Neurological Disorders. 3, 1, p. 3-13 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Interferon beta-1a 100%
  • Relapsing-Remitting Multiple Sclerosis 83%
  • Mycophenolic Acid 78%
  • Multiple Sclerosis 59%
  • Placebos 46%
  23 Scopus citations

• A p74 common gamma receptor chain isoform facilitates IL-2 and IL-15 responses by the myelomonocytic cell line Tf-1β2

  Monson, N. L., Fenske, T. J., Wei, S., Okragly, A. J., De Jong, J. L. O., Haak-Frendscho, M., O'Shea, J., Djeu, J. & Sondel, P. M., 2001, In: Journal of Leukocyte Biology. 69, 3, p. 419-425 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Interleukin-15 100%
  • Interleukin-2 70%
  • Protein Isoforms 63%
  • Cell Line 46%
  • anti-c antibody 33%
  2 Scopus citations